Skip to search formSkip to main contentSkip to account menu

Hirulog

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Summary Current therapeutic use of heparin as an adjunct to thrombolytic therapy for myocardial infarction is suboptimal with… 
1997
1997
Summary A canine model of electrolytic injury-induced coronary artery thrombosis and rtPA-induced thrombolysis was used to… 
Review
1997
Review
1997
Heparin, the most widely used antithrombin, suffers several limitations, including high inter-individual variability of… 
Review
1997
1996
1996
Although hirulog, a specific, direct inhibitor of thrombin, can prevent thrombosis in unstable angina and angioplasty without… 
Review
1995
Review
1995
&NA; Recombinant hirudin and hirudin analogues constitute interesting new antithrombotic agents that have distinct advantages… 
1994
1994
Coronary artery obstruction is currently being treated with a number of invasive approaches involving catheter based angioplasty…